Stocksigma LogoStocksigma Logo

ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 2,010 (-22.9% YoY | +31.4% QoQ) ■ EBITDA: -26.4 (Profit to Loss YoY | +86.5% QoQ) ■ EBITDA Margin (%): -1.3 (Profit to Loss YoY | +1145 bps QoQ)

ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

ANG Lifesciences India Ltd · Outcome · 15 Nov 2026, 2:53 am

ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 2,010 (-22.9% YoY | +31.4% QoQ) ■ EBITDA: -26.4 (Profit to Loss YoY | +86.5% QoQ) ■ EBITDA Margin (%): -1.3 (Profit to Loss YoY | +1145 bps QoQ) ■ PAT: -209 (+29.1% YoY | +50.8% QoQ) ■ EPS (INR): -1.59 (+29.0% YoY | +50.9% QoQ) ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Pharmaceuticals ■ Revenue: 1,858 (-28.5% YoY | +33.1% QoQ) ■ EBIT: -171 (Profit to Loss YoY | +37.6% QoQ) ■ EBIT Margin (%): -9.2 (Profit to Loss YoY | +1043 bps QoQ) Printing and packagings ■ Revenue: 210 (+85.8% YoY | -0.9% QoQ) ■ EBIT: 17.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 8.2 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from ANG Lifesciences India Ltd

All ANG Lifesciences India Ltd announcements